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Abstract
In this chapter, we review the basics of retinal vascular anatomy and discuss 
the physiologic process of retinal blood flow regulation. We then aim to explore 
the relationship between intraocular pressure and retinal circulation, taking into 
account factors that affect retinal hemodynamics. Specifically, we discuss the 
concepts of ocular perfusion pressure, baro-damage to the endothelium and trans-
mural pressure in relation to the intraocular pressure. Finally, we demonstrate the 
inter-relationships of these factors and concepts in the pathogenesis of some retinal 
vascular conditions; more particularly, through examples of two common clinical 
pathologies of diabetic retinopathy and central retinal vein occlusion.
Keywords: retinal hemodynamics, baro-damage, ocular perfusion pressure,  
diabetic retinopathy, central retinal vein occlusion, blood flow
1. Introduction
The retina shares similar anatomical features and physiological properties 
with other end organs such as the brain and the kidney, namely the presence of 
blood–brain, blood-kidney and blood-retina barrier as well as non-anastomotic end 
arteries [1]. Retinal fundoscopy and digital imaging have allowed for retinal micro-
vascular abnormalities to be directly and non-invasively identified and studied as 
a means of better understanding the manifestation of systemic microcirculatory 
disorders.
Although not yet completely understood, hemodynamic factors such as perfu-
sion pressure, blood viscosity, vascular resistance and the variations on vessel cali-
ber that ensue, determine the blood supply and flow to the retina. By understanding 
these processes and their disturbances, we can better characterize the pathological 
processes that occur in many ocular and systemic diseases such as glaucoma, age-
related macular degeneration and diabetic retinopathy, to name a few.
Retinal hemodynamics are influenced by a number of factors. Blood flow, arte-
rial and venous pressure, vascular resistance, and blood viscosity all play important 
roles. Our understanding of their inter-relationship is derived from concepts used 
in fluid flow systems borrowed from engineering and from other physiologic 
studies of blood flow. Mathematically, this relationship is often simplified into 
Poisseuille’s equation, which we will discuss more in detail in the diabetic retinopa-
thy section. However, it is important to know that Poisseuille’s equation is used 
mainly for Newtonian fluid in a system with laminar flow. In the retinal arterioles, 
the flow is often turbulent; and blood itself is not truly a Newtonian fluid. In this 
chapter, we will not delve into the detailed discussions of mathematical modeling, 
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but will only use them to better understand the hemodynamics and its biologic 
consequences.
Clinical evidence for the relationship between intraocular pressure (IOP) and 
retinal hemodynamics remains inconsistent and difficult to interpret. The reasons 
are two-fold. Firstly, it is difficult to capture the data of multiple variables that 
may contribute to hemodynamics in a clinical setting. Second, in a complex system 
such as retinal circulation, many variables act as both dependent and as inde-
pendent variables in many feed-back loops. Moreover, these feed-back loops may 
vary depending on the underlying disease processes in individuals with multiple 
 co-morbidities [2, 3].
2. Blood supply to the posterior segment
2.1 Retinal blood supply
The metabolic demands and the oxygen requirement of the retina are met by two 
distinct vascular systems. The inner two thirds of the retina is supplied by inherent 
intra-retinal vessels, fed by the central retinal artery, and drained via the central 
retinal vein. The photoreceptors and outer one third of the retina are supplied by 
the choroidal circulation [4]. Both of these supplies originate from the ophthalmic 
artery, which itself is a branch of the internal carotid artery.
The central retinal artery traverses through the orbital portion of the optic 
nerve, entering the optic disc through the lamina cribrosa. At the optic nerve, there 
is a combination of choroidal and retinal arterial circulation, details of which are 
dealt with in other chapters. The central retinal artery branches into four principal 
intra-retinal arteries. These further bifurcate into increasingly smaller arterioles, 
feeding eventually into a capillary bed as they extend towards the peripheral retina 
(Figure 1).
These capillary beds form interconnecting networks linking terminal branches 
of pre-capillary arterioles and post-capillary venules. Although in the juxta-papil-
lary region this is arranged in three layers, the peri-macular region has two layers; 
a superficial layer located in the nerve fiber and ganglion cell layers and a second, 
deeper layer in the inner nuclear and outer plexiform layers. With the exception of a 
small avascular rim, both superficial and deep plexi reach almost to the edge of the 
human retina [6, 7]. The fovea is also avascular, receiving adequate oxygenation via 
the choroidal circulation [8].
Figure 1. 
(A) Sagittal drawing of the human eye showing the retinal and choroidal circulation of the left eye. (B) Cross-
sectional drawing of the retinal and choroidal vasculature at the level of the fovea. Adapted from Anand-Apte 
and Hollyfield with drawings by Dave Schumick [5].
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Post-capillary venules feed back into the superior and inferior hemi-central 
retinal veins, eventually uniting into the central retinal vein which centralizes at 
variable depths within the optic nerve eventually draining into the cavernous sinus.
The neighboring endothelial cells lining the retinal vasculature form tight junc-
tions. Together with pericytes, they form a highly selective semi-permeable border 
that prevents solutes in the circulating blood from non-selectively crossing into the 
interstitial space within the neuroretina, constituting the inner blood retina barrier.
2.2 Choroidal blood supply
The choroid has approximately 80% of the total ocular blood supply relative 
to iris-ciliary body and retina [9] and consists of three distinct layers of gradually 
decreasing vessel caliber; Haller’s layer comprises the outer, larger sized vessels, 
Sattler’s layer is intermedial with medium-sized vessels, and the deeper choriocapil-
laris contains vessels with the smallest diameter [10]. The anterior choroid is sup-
plied by the long ciliary arteries, whereas the posterior choroid is supplied by the 
short posterior ciliary arteries. The entire choroid drains into the vortex veins [11].
Unlike the retinal vasculature, choroidal capillaries are fenestrated, allowing 
free passage and exchange of intravascular contents and interstitial space, including 
macromolecules and cellular components. It is the monolayer of retinal pigment 
epithelial cells, with tight junctions at the apical aspect, that form the outer blood-
retinal barrier (Figure 1).
2.3 Blood supply to the optic nerve head
The blood supply to the optic nerve head is complex, deriving from both the 
central retinal artery and from the choroid through the short posterior ciliary 
 arteries. It has been specifically discussed in an earlier chapter in this book.
3. Blood flow within the posterior segment
3.1 Retinal blood flow
The human retina is a metabolically demanding tissue. Tissue damage and cell 
death can be brought about by small alterations in oxygenation or blood flow; 
hypoperfusion leads to hypoxia and ischemic damage; [12] whilst hyperperfusion 
and/or high oxygen tension leads to formation of reactive oxygen species, leading 
to oxidative damage [13]. Retinal blood flow must necessarily be highly regu-
lated, and is dependent on the relationship between perfusion pressure and local 
 resistance [11].
Under physiological conditions, retinal arterial pressure is more or less equal to 
mean arterial blood pressure and retinal venous pressure is more or less equal to the 
IOP. The difference between these pressures constitutes the driving force propelling 
blood through ocular capillary beds. In general, mean ocular perfusion pressure 
(MOPP) is positively correlated with arterial blood pressure and negatively cor-
related with IOP [14].
MOPP, defined as the difference between two-thirds of the mean arterial pres-
sure (MAP) and the IOP, is a clinically modifiable factor in diseases such as Diabetic 
retinopathy (DR) where there is altered tissue perfusion. This will be reviewed in 
more detail later in the chapter.
The normal retinal hemodynamic response to increases in perfusion pressure 
is an increase in vascular resistance, [15] otherwise referred to as the myogenic 
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Figure 2. 
Schematic of blood flow autoregulation in the eye. When fluctuations in ocular prefusion pressure exceed 
the autoregulation range defined by this plateau, vasomotor adjustments are incomplete and blood flow 
changes passively as ocular perfusion pressure changes. Figure adapted with permission from Wareham and 
Calkins [18].
response. This behavior is intrinsic to smooth muscle cells such as those that line 
retinal arterioles and is independent of metabolic and hormonal influences.
3.2 Choroidal blood flow
Whilst retinal blood flow is characterized by a low perfusion rate, a high vascu-
lar resistance and a high oxygen extraction, the choroid, by contrast, shows a low 
vascular resistance, high perfusion rate and low oxygen extraction [11]
4. Regulation of blood flow in the posterior segment
4.1 Retinal blood flow regulation
Ordinarily, blood flow is regulated in response to changes in perfusion pressure 
and tissue oxygen tension.
Retinal circulation differs from blood flow in other non-neural systems in that 
local neural activity can evoke localized changes in blood flow. This behavior, 
termed neurovascular coupling, has been observed in the retina [16, 17] and is an 
emerging area of research in glaucoma [18].
More importantly, the regulatory effect of perfusion pressure on blood flow is 
blunted through the process of autoregulation. That is, the retinal blood flow, like 
that of the blood flow in the brain, is maintained or stabilized through a wide range of 
variations of perfusion pressure. Previous studies have shown that retinal autoregula-
tion is adequately compensated in experimental elevations of IOP up to 29 mmHg, 
[19] whilst the retinal vasculature behaves more passively for greater increases in IOP 
[20]. This autoregulatory response is also noted in incidences of increased perfusion 
pressure such as periods of dynamic and static exercise; where a rise in perfusion 
pressure of up to 34% rise results in a rise in flow of only 4–8% [21, 22]. Teleologically, 
autoregulation is a protective mechanism to maintain a steady blood flow to the retina 
5
Retinal Vascular Implications of Ocular Hypertension
DOI: http://dx.doi.org/10.5772/intechopen.98310
to satisfy its metabolic demands which changes very little as compared to the wide 
swings of systemic blood pressure and even diurnal variations of IOP.
The autoregulation curve (Figure 2) shows how blood flow changes in response 
to ocular perfusion pressure. The curve includes a plateau region across a range of 
ocular perfusion pressures where the blood flow is fully compensated by the above 
mentioned autoregulatory mechanisms.
4.2 Choroidal blood flow regulation
Choroidal blood flow regulation is distinctly different from that of the retina; 
[23]. Firstly, the choroidal vascular bed is extensively innervated [24] though only 
partly autoregulated. There is little to no oncotic pressure gradient between intra- 
and extravascular spaces within the choroid due to capillary fenestration. This lack 
of oncotic pressure coupled with the absence of lymphatic vessels, allows for the 
onset of choroidal effusion if the IOP drops below a certain level.
5. Effect of intraocular pressure on retinal hemodynamics
The high metabolic and oxygen demand posed by retinal tissue is met by 
maintaining a steady blood flow. IOP is a major determinant of both retinal vascular 
perfusion pressure as well as vascular transmural pressure.
Over the past two decades, elegant mathematical modeling has been used to 
assess the effect of IOP elevation on the lamina cribrosa [25–27] and on arteriove-
nous distribution within the retinal microvasculature [28, 29].
Clinical evidence of the impact of IOP on retinal blood flow and velocity is incon-
sistent. Whilst several clinical studies have shown that as IOP increases, retinal and 
retrobulbar blood flow decreases, [30–32] others have not found this to hold true in 
various settings including post-operative trabeculectomy patients [33] and in patients 
treated with IOP lowering medications [34–36]. These inconsistencies are likely due 
to numerous factors, including arterial blood pressure and blood flow autoregula-
tion [2] and the intrinsic difficulty of evaluating the individual contribution of these 
factors in a clinical setting. In organs where autoregulation is maintained, perfusion 
pressure is a weak parameter in altering blood flow within that organ.
In disease conditions, when autoregulation is disturbed, or absent, perfusion 
pressure as a determinant of blood flow becomes paramount. The role of arterial 
pressure and IOP can be easily understood in the following ways;
1. When the perfusion pressure is too high, there will be increased blood flow as 
well as increased transmural pressure within the retinal vasculature. This leads 
to endothelial damage (baro-damage) and the breakdown of the blood-retinal 
barrier. The endothelial damage, together with increased transmural pressure, 
leads to exudation and extravasation of blood products, causing retinal edema. 
Clinically, this series of events can be caused by an acute rise in blood pressure 
such as seen in malignant hypertension. It can also be seen after ocular filtra-
tion surgery when there is a significant reduction in IOP outside the range of 
autoregulation. In hypotony maculopathy, for example, we may often note 
optic disc swelling and tortuous vessels, and also macular edema and subreti-
nal fluid, albeit more rarely.
2. Conversely, when the perfusion pressure is too low, the blood flow will fall 
below that required to maintain retinal metabolic and oxygen demand, thus 
leading to ischemia. This is seen in a number of examples:
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i. In acute central retinal artery occlusion (CRAO) when an embolus blocks 
the retinal circulation of the central retinal artery at the optic disc thus 
leading to reduced blood flow and therefore widespread retinal ischemia. 
Anecdotal evidence from clinical experience has shown that reducing 
the IOP may aid in reversing the occlusion, such as when performing an 
anterior chamber paracentesis to rapidly reduce the IOP [37].
ii. In some patients with aortic stenosis or with carotid artery occlusion, 
perfusion pressure at the optic nerve head can become significant lower 
and fall outside the autoregulatory range. Any variations in systemic blood 
pressure or IOP may then cause a large enough drop in blood flow within 
the retinal vasculature, leading to ischemic damage to the retina ranging 
from mild form such as paracentral acute middle maculopathy (PAMM) or 
severe ischemia such as CRAO.
Furthermore, the picture may be complicated in cases where a state of low 
perfusion is maintained at the limits of autoregulation on a more chronic basis. 
Here there is no sudden event causing an ischemic infarct such as is seen in CRAO or 
PAMM, but rather there may be enough persistent venous stasis to induce a clinical 
picture reminiscent of Central retinal vein occlusion (CRVO), in a condition com-
monly known as Ocular ischemic syndrome or venous stasis retinopathy.
6. Effect of ocular hypertension in clinical retinopathies
The effect of IOP in retinal vascular diseases is well documented. Ocular hyper-
tension (OHT) is a risk factor for the development of CRVO. On the other hand, 
OHT seems to have a protective effect on the development and progression of DR.
6.1 Retinal vein occlusions
Retinal vein occlusion (RVO) is one of the most common retinal vascular disor-
ders, with a prevalence as high as 4.6% in adults 80 years or older, [38] and can be 
seen in the central retinal vein (CRVO) or in branched veins (BRVO). Although the 
underlying mechanisms governing RVOs are multifactorial, Virchow’s triad teaches 
that a combination of blood flow stasis, endothelial cell damage and hypercoagula-
bility leads to thrombosis [39].
In CRVOs, the proximity of the central retinal vein and artery (enveloped in a 
common fibrous tissue) to one another within the optic disc means that the pres-
ence of arterial disease such as systemic hypertension and arteriosclerosis, can 
predispose the central retinal vein to a pre-morbid low flow state. Additional risk 
factors for RVOs include coagulation disorders and hyper viscosity states, but one of 
the most frequently encountered risk factors is glaucoma/OHT. In BRVOs, hemo-
dynamic changes occur at arteriovenous crossings coupled with altered blood flow 
thus leading to localized venous compression [40].
Verhoeff first described the relationship between glaucoma and CRVO in 
1913, where he postulated that increased IOP compresses and collapses the wall 
of the central retinal vein, leading to intimal proliferation within the vein [41]. 
Whereas primary open angle glaucoma (POAG) is a feature which precedes CRVO 
in between 10 and 40% of patients, [Larsson] the prevalence of POAG in BRVO 
appears to be less frequent at between 6 and 15% [42, 43].
Many studies have analyzed the relationship between glaucoma and RVO risk, 
with contradictory outcomes. Yin et al. recently performed a meta-analysis of 
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research conducted between 1977 and 2015, examining the relationship between 
glaucoma and RVO and found glaucoma to be a core risk factor for RVO in 15 stud-
ies with high methodological quality [44]. The studies reviewed have suggested a 
number of different potential hypotheses;
• Some have considered that glaucoma and RVO are both manifestations of an 
underlying vascular abnormality or vascular dysregulation. Both conditions 
share similar risk factors; hyperlipidemia, smoking habits, abnormal plasma 
viscosity and inflammatory activity [45–47]. Other abnormalities found with 
raised fibrinogen and IgA are also consistent, implying that associated medical 
conditions are of greater significance to deterioration in RVOs rather than the 
presence of glaucoma or OHT itself.
• POAG has been found to precede vascular occlusion [48–51] and disc hemor-
rhage is frequently seen in POAG patients in the clinic, leading to the hypoth-
esis that RVO and POAG might share a common pathogenesis [52].
• In patients with compromised retinal circulation and autoregulatory mecha-
nisms, a minor rise in IOP may be high enough to reduce ocular blood flow 
sufficiently to propagate stagnant blood flow. This hypothesis is supported 
by the finding of a reduction in IOP thresholds, normally estimated to be 
27-30 mmHg in patients with chronic simple glaucoma, up to which auto-
regulation, by increasing arterial pressure with decreased vascular resistance, 
maintains normal blood flow [53].
• Some groups have presented a vascular hypothesis of glaucoma; [54] individu-
als with primary angle closure glaucoma as well as POAG are known to have nar-
rower retinal arteries and veins than normal subjects [55]. Therefore elevated 
IOP may lead to greater vessel wall compression in these “primed” vessels, 
leading to vein intimal proliferation and collapse of retinal capillaries [56, 57].
Although glaucoma and OHT are risk factors for CRVO, once CRVO is estab-
lished, there is a curious phenomenon of lowered IOP in the eye with the RVO as 
compared to the fellow, non-affected eye. The exact cause of this lowering of IOP 
is not understood, though Hayreh et al. postulated it may be due to the release of 
soluble factors induced by relative ocular ischemia [58].
This lowered IOP, combined with increased venous pressure, increases the 
capillary hydrostatic pressure according to Starling’s Law [59]. This in turn leads to 
increased leakage from compromised endothelial cells; the clinical presentation of 
which is seen as macular edema and hemorrhagic retinopathy.
In fluid dynamics, Bernoulli’s principle states that an increase in the speed of a 
fluid (kinetic energy) occurs simultaneously with a decrease in static pressure or 
a decrease in the fluid’s potential energy. The converse is the case in severe CRVO 
where the venous thrombosis causes significant slowing down of blood flow velocity, 
the kinetic energy that drives the blood flow forward within the capillary network 
can be reduced enough to cause intra capillary thrombosis, as evidenced in wide 
spread capillary drop out on fluorescein angiography. When enough retinal area is 
involved (usual criteria is 10 disc areas on angiography), the resulting ischemia may 
lead to neovascular complications. This is referred to clinically as ischemic CRVO. 
At the same time, according to Bernoulli principle of total energy conservation, the 
decrease in kinetic energy will result in a commensurate increase in the potential 
energy as expressed in lateral or transmural pressure. This increase in lateral pressure 
causes extravasation of fluid into the interstitial space and results in retinal edema.
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Whilst our current approach to the management of RVO incorporates addressing 
associated systemic risks common to both glaucoma and RVO, further work is needed 
to establish the exact effects of elevated IOP as well as the additional effect of glau-
coma medications on the autoregulatory capacity of retinal blood flow e.g. timolol 
enhancing autoregulation and thus possibly aiding perfusion following RVOs [60].
6.2 Diabetic retinopathy
DR continues to be one of the leading causes of blindness globally, and as 
retinal capillaries can be visualized directly, the progression of DR can be continu-
ously assessed. The microangiopathic processes noted in the retina are echoed in 
the glomeruli of diabetic patients. The glomerular microcirculation has received 
significant attention as it’s accessibility to both clinical and experimental observa-
tion is unique, in that fluid and macromolecule movement across capillary walls 
can be easily quantified [61]. Glomerular hemodynamic abnormalities, as with the 
microcirculation in the retina, are thought to be mediated by a complex chain of 
events including direct mechanical injury (baro-damage) to the capillaries, [62] and 
subsequent intracapillary coagulation [63]. As with renal microcirculation, hemo-
dynamic abnormalities within the retinal microcirculation can be detected many 
years before DR becomes overt.
Multiple factors, including altered levels of vasoactive substances, altered vaso-
motor responsiveness and persistent hypoxia leads to marked venous vasodilation. 
Although the consequent elevations in capillary pressure and blood flow may be the 
inciting mechanism for the onset of diabetic microangiopathy, the factors linking 
hyperglycemia to vascular cell dysfunction, capillary dropout, tissue hypoxia, and 
abnormal angiogenesis, remain poorly described [64, 65]. Patients with diabetes 
are however known to have dysfunctional retinal perfusion [66] and an abnormal 
autoregulatory capacity [67].
The retinal microcirculation is sensitive to local variations in oxygen tension, 
with capillary blood flow and vessel diameter varying as necessary in response to 
local metabolic demand; [61] retinal capillaries dilate with low ambient oxygen 
tensions, and constrict with high ambient oxygen tensions [68].
As DR progresses, capillary microaneurysms, exudates and hemorrhages are 
seen, followed by endothelial proliferation with neovascularization. In the latter 
stages, focal retinal atrophy and vitreous body adhesions occur, eventually lead-
ing to tractional retinal detachment if not treated. These advancing stages of DR 
are characterized by local capillary basement membrane thickening, endothelial 
proliferation and intracapillary thrombosis, the latter of which further aggravates 
endothelial proliferation. This cascade results in capillary lumen obstruction, exac-
erbated even more so in the presence of hypoxia. Over time, retinal microvascular 
damage in the presence of persistent hypoxia results in elevated intraocular vascular 
endothelial growth factor (VEGF), an endothelial-specific diffusible factor that 
mediates permeability and development of vasculature.
That hemodynamic factors play an important role in the development of DR is 
evident in many clinical observations. Generally, disease states that cause an eleva-
tion in retinal perfusion pressure hastens the onset of DR. When retinopathy is 
already established, the same high perfusion state can cause a more rapid progression 
of the retinopathy. Conditions that cause perfusion pressure to increase include:
i. Systemic hypertension
The United Kingdom Prospective Diabetes study (UKPDS) found that 
improved blood pressure control decreased the progression of diabetic 
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microangiopathy and correlated with a reduction in risk of cerebrovascular 
incidents by more than a third [69].
ii. Pregnancy
It is widely recognized that pregnancy worsens during pregnancy [70–72]. 
DR severity pre-pregnancy, metabolic control during pregnancy and 
pregnancy related hypertension have all be identified as risk factors for this 
worsening [70, 72]. Increased cardiac output and plasma volume during 
pregnancy, as well as a decrease in peripheral vascular resistance signifi-
cantly increase blood flow to different parts of the body, including the retinal 
vasculature. Chen et al. have shown that when increased blood flow was 
documented in the first trimester, DR progressed, in contrast to unchanging 
DR severity in women whose retinal blood flow remained unchanged [73]. 
The hyperdynamic circulatory state induced by pregnancy is counteracted 
effectively only if normal autoregulatory control of blood flow is main-
tained. In some diabetic pregnant women, these mechanisms are flawed, 
where increased blood flow potentially inflicts endothelial damage by incit-
ing additional shear stress at the capillary level.
Conversely, disease state that leads to a decrease in retinal perfusion pressure 
may protect against the development or the progression of DR.
6.2.1 Carotid stenosis
It is noted that patients with carotid artery disease may have eyes with asym-
metric severity of DR; with the less affected eye having an ipsilateral carotid artery 
that is more obstructed. The protective effect has been attributed to the reduction in 
the retinal arterial perfusion pressure [74]. It should be noted that when the carotid 
occlusion becomes severe, that is exceeding 90% of the vessel caliber, this protec-
tive effect is lost due to consequent ischemia [75].
6.2.2 Optic atrophy
A similar asymmetric DR severity can be seen in patients with optic atrophy. 
The side with optic atrophy has severe DR compared to the side with a normal optic 
nerve. This can be explained by the narrowing of the retinal arterioles generally 
seen in eyes following the onset of optic atrophy [76, 77]. In these eyes, although the 
arterial pressure at the optic nerve head may not be altered, the capillary perfusion 
pressure is much reduced due to the narrowing of the vessel caliber.
The relation between vessel caliber and end capillary perfusion pressure can be 
understood through Poisseuille’s blood flow equation: [78].
 2p 8 LQ / R4 8 LQ /A∆ = µ π = µ  (1)
where:
Δp is the pressure difference between the two ends (pressure drop) L is the 
length of pipe (distance blood travels to reach capillary bed) μ is the dynamic 
viscosity.
Q is the volumetric flow rate (blood flow).
R is the pipe radius (vessel caliber).
A is the cross section of pipe (vessel cross sectional area).
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Note that the drop in perfusion pressure at the capillary level is inversely cor-
related to the square of the cross sectional area of the vasculature. The narrower 
the vessel caliber, the smaller the cross sectional area, the drop in perfusion at the 
capillary level is increased by the fourth power of the radius of the vessel.
6.2.3 Myopia
In patients with anisometropia where one eye is significantly more myopic than 
the other, it is the eye with higher myopia that demonstrates less severe DR levels 
[79, 80]. Myopic eyes tend to have longer axial lengths, consequently for every cor-
responding point in the retina, the arteriole has to travel further to reach compared 
to that in an eye with a normal axial length. This increased blood travel, can be 
simplified as having comparatively longer vessel or pipe length, with a consequent 
decrease in end capillary perfusion. Mathematically, we can once again understand 
it through Poisseuille’s equation: as L increases, Δp increases also, meaning a drop in 
the capillary perfusion pressure.
6.2.4 Ocular hypertension and glaucoma
Whereas the clinical evidence from the above mentioned examples of asym-
metric DR seems to point to the general idea that an increase in end capillary 
perfusion pressure is a main risk for the development or worsening of DR, studies 
directly examining the association between MOPP and DR are rare. Many studies 
have assessed the relationship between retinal blood flow and DR [81–84]. Whilst 
a series of studies have reported that increased retinal blood flow is associated with 
background DR, [81, 82] pre-proliferative DR, and proliferative DR, [81] as with 
RVO, data on the relationship of the effect of MOPP remains inconsistent globally. 
Whilst some researchers have shown higher MOPP is associated with DR, macular 
edema, and hard exudation, [81, 85] others did not observe this association [86].
The pathophysiology of glaucoma is not completely understood. However, both 
diabetes and glaucoma appear to share some common risk factors and pathophysi-
ologic similarities, including the phenomenon of neurovascular coupling (NVC). 
Within the retina, studies have shown that not only is vascular dilatation reduced 
in patients with little to no DR, but also in glaucoma patients when compared to 
that in healthy subjects [87–89]. These studies indicate a process whereby abnormal 
neurovascular coupling precedes a visible angiopathy in humans in both glau-
coma and DR.
Several population-based studies have shown a positive association between 
ocular hypertensive disorders and diabetes mellitus [90–92] whilst some shown 
a negative association [93, 94]. Becker et al. showed that glaucoma decreased the 
incidence of DR and postulated this was because the increase in IOP lowered the 
transmural hydraulic pressure gradient across retinal capillaries [95].
Some groups have postulated that the reduced number of retinal ganglion cells 
found in glaucoma lead to a reduced ischemic drive and thus prevents DR develop-
ment [96, 97]. Singal et al. showed that the mean duration of diabetes with early 
non-proliferative changes was maximum in patients with primary open angle 
glaucoma (15.8 years), followed by normal tension glaucoma (14.0 years) and then 
in non-glaucomatous patients (13.3 years) [96]. They also observed that advanced 
stages of DR changes were seen more so in the group without glaucoma. These find-
ings, alongside those of Williams et al., suggests that not only does glaucoma delay 
the onset of DR, but that glaucoma also has an effect in delaying the progression of 
DR changes [96, 97].
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The protective effect of ocular hypertension and glaucoma on DR can also be 
understood through the hemodynamic changes.
Increased IOP causes a decrease in ocular perfusion pressure. This directly 
reduces endothelial baro-damage. Also, in patients with established glaucoma with 
significant optic atrophy, the resultant arteriole narrowing would additionally cause 
a significant increase in vascular resistance and a decrease in end capillary perfu-
sion as demonstrated through Poisseuille’s equation.
6.2.5 Pan retinal laser photocoagulation (PRP)
PRP is an effective treatment against proliferative DR. The DRS study showed 
that the 5 year rate of severe vision loss from proliferative DR was reduced from 
50% without PRP to 20% by this treatment, as onset and progression of neovas-
cularization was prevented. Furthermore, PRP reduced the risk of elevated IOP 
during the study period thus delaying onset of neovascular glaucoma [98]. It’s 
therapeutic effect is understood to be due to the reduction of oxygen and metabolic 
demand through tissue ablation. It should be pointed out that after PRP, the arte-
riole calibers are decreased significantly, resulting in a marked reduction of end 
capillary perfusion pressure.
6.2.6 Anti-VEGF intravitreal injections
Development of injectable anti-VEGF agents into the eye have revolutionized 
the way in which diabetic macular edema and proliferative DR can be managed. 
Multiple pivotal trials reproducibly demonstrated significant regression of DR 
severity with anti-VEGF treatments, [99–101] as well as complete regression of new 
vessels in up to 20% of cases [102]. It has also been noted that in diabetic macular 
edema treatment, the number of injections needed to control macula edema 
decreases in the second and third year as compared to the first year of treatment 
[99]. These findings suggest that continued anti-VEGF, with attendant restoration 
of healthier hemodynamics, a reduced capillary perfusion pression and less baro-
damage to the capillary endothelium may confer some improvement in the severity 
of retinopathy.
7. Conclusions
A comprehensive review of retinal hemodynamics, the interplay between 
various factors such as blood pressure, vascular resistance, IOP, ocular perfusion 
pressure and blood flow are covered in this chapter. Changes in one of more of 
these factors are discussed in different disease states. Specifically, we discussed two 
important and frequent clinical entities; CRVO and DR. IOP plays an important role 
in the pathogenesis of each of these two conditions. In eyes with predispositions to 
venous stasis, IOP causes a further reduction in ocular perfusion and thus exacer-
bates the stasis. On the other hand, in diabetic microangiopathy, the endothelium is 
damaged, so that an increased IOP with attendant reduction in perfusion pressure 
actually protects the endothelium from transmural pressure related trauma.
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